Loading
Latest filing published 28 Jun 2024 for Gland Pharma Limited, €28k.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by Bh Lenin Kumar Raja on record concern Gland Pharma Limited, in the capacity of chief executive. Over a trading history stretching from 5 July 2021 to 27 June 2024, the count stands at 16 filings.
Every open-market trade on record is a sale: 14 sales worth €533k. Outside the open market, there are 2 share grants. Since January 2024: no purchases and 2 sales on the market.
On 28 June 2024 came the latest disclosure, an open-market sale for €28k in Gland Pharma Limited. The median gap between a trade and its publication by SEBI (PIT + SAST) is 1 day. This delay matters because a trade only becomes useful information once it is public. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations